PillRx only · Injection · Intravenous
Enoxaparin Sodium
Brands: Lovenox · Enoxaparin Sodium
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$9.929
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
5
Active US suppliers
44%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.6K
Rx · 2026 Q1
21K
Units dispensed
-4%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 2 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 2 | SUPPLYING |
| BluePoint Laboratories | unknown | 2 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Amphastar Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.